AFAP1L2 | Actin filament associated protein 1-like 2 | | | | | | Tissue enhanced |
C16orf89 | Chromosome 16 open reading frame 89 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDON | Cell adhesion associated, oncogene regulated | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CNTN5 | Contactin 5 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COL8A1 | Collagen, type VIII, alpha 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DCDC2 | Doublecortin domain containing 2 | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
DOCK3 | Dedicator of cytokinesis 3 | Disease related genes
| | | | | Tissue enhanced |
FNDC1 | Fibronectin type III domain containing 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
FRAS1 | Fraser syndrome 1 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GLIS3 | GLIS family zinc finger 3 | Disease related genes Predicted secreted proteins Transcription factors
| | | | | Tissue enhanced |
KCNAB1 | Potassium voltage-gated channel, shaker-related subfamily, beta member 1 | Transporters
| | | | | Tissue enhanced |
KCNIP3 | Kv channel interacting protein 3, calsenilin | Predicted secreted proteins
| | | | | Tissue enhanced |
KCNJ15 | Potassium inwardly-rectifying channel, subfamily J, member 15 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCTD8 | Potassium channel tetramerization domain containing 8 | Predicted membrane proteins
| | | | | Tissue enhanced |
KHDRBS2 | KH domain containing, RNA binding, signal transduction associated 2 | | | | | | Tissue enhanced |
KLHL14 | Kelch-like family member 14 | | | | | | Tissue enhanced |
KRT7 | Keratin 7 | Plasma proteins
| | | | | Tissue enhanced |
LPCAT2 | Lysophosphatidylcholine acyltransferase 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
LRP2 | Low density lipoprotein receptor-related protein 2 | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MARVELD2 | MARVEL domain containing 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
NTRK2 | Neurotrophic tyrosine kinase, receptor, type 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
PDE1A | Phosphodiesterase 1A, calmodulin-dependent | Enzymes
| | | | | Tissue enhanced |
PRTG | Protogenin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RAP1GAP | RAP1 GTPase activating protein | | | | | | Tissue enhanced |
RPS6KA6 | Ribosomal protein S6 kinase, 90kDa, polypeptide 6 | Enzymes
| | | | | Tissue enhanced |
SALL4 | Spalt-like transcription factor 4 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
SHISA2 | Shisa family member 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
SLC12A8 | Solute carrier family 12, member 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SMAD9 | SMAD family member 9 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
SORCS1 | Sortilin-related VPS10 domain containing receptor 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
TRIB3 | Tribbles pseudokinase 3 | Enzymes
| | | | | Tissue enhanced |
UST | Uronyl-2-sulfotransferase | Predicted membrane proteins
| | | | | Tissue enhanced |